NovelN-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1mAChR Agonists
- 8 June 2010
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 1 (6) , 244-248
Abstract
Virtual screening of the corporate compound collection yielded compound 1 as a subtype selective muscarinic M1 receptor agonist hit. Initial optimization of the N-capping group of the central piperidine ring resulted in compounds 2 and 3 with significantly improved potency and selectivity. Subsequent optimization of substituents on the phenyl ring of the benzimidazolone moiety led to the discovery of novel muscarinic M1 receptor agonists 4 and 5 with excellent potency, general and subtype selectivity, and pharmacokinetic (PK) properties including good central nervous system (CNS) penetration and oral bioavailability. Compound 5 showed robust in vivo activities in animal models of cognition enhancement. The combination of high potency, excellent selectivity, and good PK properties makes compounds 4 and 5 valuable tool compounds for investigating and validating potential therapeutic benefits resulting from selective M1 activation.Keywords
This publication has 18 references indexed in Scilit:
- 2′ Biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profilingBioorganic & Medicinal Chemistry Letters, 2010
- Muscarinic receptors prevent oxidative stress‐mediated apoptosis induced by domoic acid in mouse cerebellar granule cellsJournal of Neurochemistry, 2009
- Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonistsEuropean Journal of Pharmacology, 2009
- Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas—The effect of capping the distal basic piperidine nitrogenBioorganic & Medicinal Chemistry Letters, 2008
- Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moietiesBioorganic & Medicinal Chemistry Letters, 2008
- The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and FingerprintsMolecular Pharmacology, 2003
- Discovery of an Ectopic Activation Site on the M1Muscarinic ReceptorMolecular Pharmacology, 2002
- International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine ReceptorsPharmacological Reviews, 1998
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990